RELAPSE LEUKEMIA
Clinical trials for RELAPSE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on aggressive leukemias that resist standard care
Disease control Recruiting nowThis early-stage study is testing whether combining two oral drugs, revumenib and mezigdomide, is safe and effective for people with specific types of acute leukemia that have returned or not responded to prior treatments. The trial will enroll about 52 participants aged 12 and o…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists hunt genetic clues to make leukemia treatment safer for kids
Knowledge-focused Recruiting nowThis study aims to understand how a child's genes might influence their risk of severe side effects and how well they respond to standard leukemia treatment. Researchers will observe about 550 Indian children with acute lymphoblastic leukemia (ALL) to find genetic markers linked …
Matched conditions: RELAPSE LEUKEMIA
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC